Łucja Dudzik
Łucja Dudzik has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Ewa Dworniczek
Department of Microbiology, Faculty of Medicine, Wroclaw Medical University, 50-368 Wrocław, Poland
2 shared publications - Paweł Krzyżek
Department of Microbiology, Faculty of Medicine, Wroclaw Medical University, 50-368 Wroclaw, Poland
2 shared publications - Paweł Migdał
Department of Bees Breeding, Institute of Animal Husbandry and Breeding, Wroclaw University of Environmental and Life Sciences, 51-630 Wroclaw, Poland
1 shared publication - Piotr Misiąg
Department of Minimally Invasive and Robotic Urology, University Center of Excellence in Urology, Wroclaw Medical University, 50-556 Wroclaw, Poland
1 shared publication
Latest Publications
- Open Access
Prevalence and β-Lactam Resistance of Enterobacterales Isolated from Urinary Samples in a Regional Hospital in Poland: Special Emphasis on Elderly Population
Urinary tract infections (UTIs) are among the most common bacterial infections worldwide. The growing prevalence of antimicrobial resistance among Enterobacterales, particularly to β-lactam antibiotics, contributes to treatment failures and prolonged hospital stays. This single-center descriptive surveillance study aimed to evaluate the distribution of Enterobacterales recovered from culture-positive urine samples in the Provincial Specialist Hospital in Włocławek, Poland, and to determine the prevalence of β-lactam resistance phenotypes among these isolates. Urine culture results collected between January and December 2025 from all hospital wards and the outpatient urology clinic were retrospectively analyzed in this study, with 1090 positive urine cultures included. For a subset of 85 isolates, microbiological findings were additionally linked with patients’ clinical characteristics. Bacteria of the genus Escherichia were the most frequently isolated (53.8%), followed by Klebsiella (22.9%) and Proteus (14.2%), with the remaining Enterobacterales genera recovered at frequencies ranging from 0.6% to 4.5%. Most isolates presented no detectable β-lactam resistance phenotype; however, resistance mediated by β-lactamase production was observed in some of them. Phenotypic ESBL and AmpC producers accounted for 25.3% and 0.6% of isolates, respectively, whereas phenotypic carbapenemase-producing strains were detected less frequently, with MBL and KPC producers representing 1.4% and 0.3% of isolates, respectively. No clear associations were identified between patient characteristics and the occurrence of specific bacterial isolates or resistance mechanisms, which may be explained by the relatively homogeneous study population, the majority of whom were ≥70 years old (66/85; 77.6%) and had a similar burden of comorbidities. In conclusion, the current level of β-lactam resistance phenotypes among urinary Enterobacterales in our setting can be considered moderate. Nevertheless, continuous surveillance of local urine-derived bacteria and their antimicrobial resistance profiles remains essential for optimizing effective control strategies.
Open AccessPrevalence and β-Lactam Resistance of Enterobacterales Isolated from Urinary Samples in a Regional Hospital in Poland: Special Emphasis on Elderly Population
Urinary tract infections (UTIs) are among the most common bacterial infections worldwide. The growing prevalence of antimicrobial resistance among Enterobacterales, particularly to β-lactam antibiotics, contributes to treatment failures and prolonged hospital stays. This single-center descriptive surveillance study aimed to evaluate the distribution of Enterobacterales recovered from culture-positive urine samples in the Provincial Specialist Hospital in Włocławek, Poland, and to determine the prevalence of β-lactam resistance phenotypes among these isolates. Urine culture results collected between January and December 2025 from all hospital wards and the outpatient urology clinic were retrospectively analyzed in this study, with 1090 positive urine cultures included. For a subset of 85 isolates, microbiological findings were additionally linked with patients’ clinical characteristics. Bacteria of the genus Escherichia were the most frequently isolated (53.8%), followed by Klebsiella (22.9%) and Proteus (14.2%), with the remaining Enterobacterales genera recovered at frequencies ranging from 0.6% to 4.5%. Most isolates presented no detectable β-lactam resistance phenotype; however, resistance mediated by β-lactamase production was observed in some of them. Phenotypic ESBL and AmpC producers accounted for 25.3% and 0.6% of isolates, respectively, whereas phenotypic carbapenemase-producing strains were detected less frequently, with MBL and KPC producers representing 1.4% and 0.3% of isolates, respectively. No clear associations were identified between patient characteristics and the occurrence of specific bacterial isolates or resistance mechanisms, which may be explained by the relatively homogeneous study population, the majority of whom were ≥70 years old (66/85; 77.6%) and had a similar burden of comorbidities. In conclusion, the current level of β-lactam resistance phenotypes among urinary Enterobacterales in our setting can be considered moderate. Nevertheless, continuous surveillance of local urine-derived bacteria and their antimicrobial resistance profiles remains essential for optimizing effective control strategies.
- Open Access
- 8 November 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (22) , 10847
A Review on the Current and Future State of Urinary Tract Infection Diagnostics
Urinary tract infections (UTIs) constitute a severe global health problem, placing a significant burden on healthcare systems worldwide. These infections often lead to frequent hospitalizations, sick leaves, and serious post-infectious complications. One of the most critical aspects of UTI treatment is rapid and accurate identification of pathogens, which increasingly develop resistance to commonly used antibiotics, as well as to newer ones, despite the expectation of sustained efficacy. This alarming trend signals the widespread presence of strains equipped with multiple resistance factors. In this review, attention has been drawn to the current classification of UTIs based on age, gender, risk factors, and preferred treatment strategies. Additionally, this article reviews diagnostic solutions used in this matter, starting from those applied in routine diagnostics and ending with the latest, cutting-edge approaches that are gradually coming into use. Each method varies in its specificity, sensitivity, and costs of implementation, and therefore, the limitations associated with adopting these technologies in widespread UTI diagnostics are also discussed. The review emphasizes the need for further research to optimize these innovations and integrate them into broad clinical practice, ultimately enabling more effective combat against UTIs and limiting the spread of bacterial resistance.
- 8 November 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (22) , 10847
Open AccessA Review on the Current and Future State of Urinary Tract Infection Diagnostics
Urinary tract infections (UTIs) constitute a severe global health problem, placing a significant burden on healthcare systems worldwide. These infections often lead to frequent hospitalizations, sick leaves, and serious post-infectious complications. One of the most critical aspects of UTI treatment is rapid and accurate identification of pathogens, which increasingly develop resistance to commonly used antibiotics, as well as to newer ones, despite the expectation of sustained efficacy. This alarming trend signals the widespread presence of strains equipped with multiple resistance factors. In this review, attention has been drawn to the current classification of UTIs based on age, gender, risk factors, and preferred treatment strategies. Additionally, this article reviews diagnostic solutions used in this matter, starting from those applied in routine diagnostics and ending with the latest, cutting-edge approaches that are gradually coming into use. Each method varies in its specificity, sensitivity, and costs of implementation, and therefore, the limitations associated with adopting these technologies in widespread UTI diagnostics are also discussed. The review emphasizes the need for further research to optimize these innovations and integrate them into broad clinical practice, ultimately enabling more effective combat against UTIs and limiting the spread of bacterial resistance.